ASSESSING CARDIOVASCULAR RISK IN PATIENTS WITH PRIMARY OSTEOPOROSIS
Main Article Content
Abstract
Objective: To survey cardiovascular risk using the SCORE_VN scale and some related factors in patients primary osteoporosis.
Methods: Cross-sectional study based on 87 patients with primary osteoporosis diagnosed using World Health Organization (WHO), who visited and treated Bach Mai Hospital, from November 2025 to December 2025.
Results: The risk of cardiovascular disease based on the SCORE-VN scale was 8.92 ± 7.15%. The proportion of patients in the low-moderate risk group was 32.2%, while 46% as high risk and 21.8% as very high risk. Regarding associated factors, the mean predicted cardiovascular risk was significantly higher in patients aged ≥70 years compared to those aged 50-69 years (19.05 ± 7.88% vs. 5.89 ± 2.90%, p<0.0001). Patients who smoked had a significantly higher cardiovascular risk than non-smokers (p=0.013). In addition, patients with a history of fracture had a 2.71-fold higher risk of cardiovascular disease compared to those without (OR = 2.71; 95% CI: 1.00 -7.34; p=0.046).
Conclusion: Patients with primary osteoporosis have a high predicted risk of cardiovascular disease. Cardiovascular risk as assessed by the SCORE_VN model is significantly associated with age, smoking status, hypertension, and a history of fractures. Therefore, cardiovascular risk assessment should be routinely performed in patients with primary osteoporosis to improve risk stratification and prevent cardiovascular events.
Keywords
cardiovasular risk, osteoporosis, SCORE_VN
Article Details
References
2. Trường Đại học Y Hà Nội. Bệnh Học Nội Khoa. Nhà xuất bản Y học, Hà Nội; 2020.
3. Veronese N, Stubbs B, Crepaldi G, et al. Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis. Journal of Bone and Mineral Research. 2017;32(5):1126-1135. doi:10.1002/jbmr.3089
4. Hai TNP, Tai NN, Kha NM, et al. Reassessing Cardiovascular Risk Stratification in Vietnam: Insights from SCORE2 and the Original SCORE Model. Acta Inform Med. 2025;33(2):112-117. doi:10.5455/aim.2025.33.112-117
5. D’Agostino RB, Vasan RS, Pencina MJ, et al. General Cardiovascular Risk Profile for Use in Primary Care. Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579
6. Sennerby U, Melhus H, Gedeborg R, et al. Cardiovascular diseases and risk of hip fracture. JAMA. 2009;302(15):1666-1673. doi:10.1001/jama.2009.1463
7. Kim DH, Rogers JR, Fulchino LA, Kim CA, Solomon DH, Kim SC. Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis. PLoS One. 2015;10(4):e0122646. doi:10.1371/journal.pone.0122646
8. Hu X, Ma S, Chen L, Tian C, Wang W. Association between osteoporosis and cardiovascular disease in elderly people: evidence from a retrospective study. PeerJ. 2023;11:e16546. doi:10.7717/peerj.16546